C07K 2317/81
Functional in the endoplasmatic reticulum [er] or the golgi apparatus
Official title: functional in the endoplasmatic reticulum [ER] or the Golgi apparatus
C07K2317/81 (Functional in the endoplasmatic reticulum [er] or the golgi apparatus) appears on 9 US grants and 11 published applications in this corpus.
Search patents in C07K- Granted patents
- 9
- Published applications
- 11
- Assignees
- 11
- Inventors
- 27
- Latest grant
- 5 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Intrabodies targeting post-translational modifications of native proteins and method for obtaining them5 Oct 2021US 11,137,393 B2Scuola Normale Superiore
- Antibody and antibody mimetic for visualization and ablation of endogenous proteins29 Aug 2017US 9,746,475 B2University of Southern California
- Diagnosis, prevention and treatment of cancer28 Oct 2008US 7,442,781 B2Urifer Ltd.
- Methods and reagents for targeting organic compounds to selected cellular locations16 May 2006US 7,045,305 B1The Regents of the University of California
- Humanized antibody and uses thereof12 Nov 2002US 6,479,284 B1Avant Immunotherapeutics, Inc.
- Intrabodies targeting post-translational modifications of native proteins and method for obtaining them3 Mar 2022US 2022/0065850 A1Scuola Normale Superiore
- Intrabodies targeting post-translational modifications of native proteins and method for obtaining them28 Nov 2019US 2019/0361013 A1Scuola Normale Superiore
- Antibody and antibody mimetic for visualization and ablation of endogenous proteins27 Dec 2018US 2018/0372750 A1
- Quinolines and their use for treating endoplasmic reticulum stress-caused diseases5 Oct 2017US 2017/0281611 A1Eiger BioPharmaceuticals, Inc.
- Antibody and antibody mimetic for visualization and ablation of endogenous proteins25 Sep 2014US 2014/0287426 A1University of Southern California
Most cited
By later US patents
- Intracellular targeting of endogenous proteins78US 6,004,940 ADana-Farber Cancer Institute, Inc. · 1999
- Method of intracellular binding of target molecules57US 5,965,371 ADana-Farber Cancer Institute, Inc. · 1999
- Method of intracellular binding target molecules49US 6,329,173 B1Dana-Farber Cancer Institute, Inc. · 2001
- Humanized antibody and uses thereof29US 6,479,284 B1Avant Immunotherapeutics, Inc. · 2002
- Method of intracellular binding of target molecules19US 6,072,036 ADana-Farber Cancer Institute, Inc. · 2000